Clinical Trials Directory

Trials / Completed

CompletedNCT05471336

Enteral Feeding and Splanchnic NIRS Values in Infants With Neonatal Encephalopathy (NE)

A Prospective Study Describing Splanchnic NIRS Values in Infants With Neonatal Encephalopathy Undergoing Therapeutic Hypothermia and Receiving Enteral Feeds

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
0 Days – 2 Days
Healthy volunteers
Not accepted

Summary

The research team plans to administer trophic enteral feeds to infants with Neonatal Encephalopathy that are undergoing therapeutic hypothermia. The team will monitor splanchnic NIRS values and compare these values to a group of historic infants who underwent hypothermia but did not receive feeds, to investigate whether there may be a range of values that can predict safe feeding. The team will also look at some clinical outcomes including feeding tolerance, time to achieve full enteral feeds, infection rates, length of hospital stay.

Conditions

Interventions

TypeNameDescription
PROCEDUREEnteral FeedingFeeds of expressed breast milk or donor breast milk will be given. Formula feeds will not be permitted. If the parents do not wish to provide donor milk, whatever volume of expressed mother's milk is available will be given up until the required volume. Feeds will be administered via orogastric or nasogastric tube and administered over 30 minutes.

Timeline

Start date
2022-09-09
Primary completion
2024-02-07
Completion
2024-03-14
First posted
2022-07-22
Last updated
2024-05-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05471336. Inclusion in this directory is not an endorsement.